,outcome,arm 1,arm 2
0,intervention,CHF,
0,Protocol-defined cardiotoxicity,2 cases,13 % of TLC D-99 patients
0,"Protocol-defined cardiotoxicity, total study group","29 % of doxorubicin patients, 9 cases, CHF","29 % of doxorubicin patients, 9 cases, CHF"
